Subscribe
ericsphotography-istockphoto-com-us-gavel-2-1
ericsphotography / iStockphoto.com
21 May 2018Americas

Federal Circuit affirms Praxair patent victory against Mallinckrodt

The US Court of Appeals for the Federal Circuit has affirmed a patent victory for industrial gases company Praxair against pharmaceutical business Mallinckrodt.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Mallinckrodt to make $1.2bn acquisition
2 January 2018   Mallinckrodt has revealed plans to acquire biopharmaceutical company Sucampo Pharmaceuticals for $1.2 billion.
Americas
Mallinckrodt sues generic company over fever treatment
2 June 2017   Mallinckrodt IP and Mallinckrodt Hospital Products, subsidiaries of pharmaceutical company Mallinckrodt, have filed a patent infringement complaint against B Braun Medical.


Editor's picks

In-house with Bayer: ‘Focus on quality early and stay close to inventors’
Europe
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
15 July 2025

Editor's picks

Europe
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025

More on this story

Americas
Mallinckrodt to make $1.2bn acquisition
2 January 2018   Mallinckrodt has revealed plans to acquire biopharmaceutical company Sucampo Pharmaceuticals for $1.2 billion.
Americas
Mallinckrodt sues generic company over fever treatment
2 June 2017   Mallinckrodt IP and Mallinckrodt Hospital Products, subsidiaries of pharmaceutical company Mallinckrodt, have filed a patent infringement complaint against B Braun Medical.

More on this story

Americas
Mallinckrodt to make $1.2bn acquisition
2 January 2018   Mallinckrodt has revealed plans to acquire biopharmaceutical company Sucampo Pharmaceuticals for $1.2 billion.
Americas
Mallinckrodt sues generic company over fever treatment
2 June 2017   Mallinckrodt IP and Mallinckrodt Hospital Products, subsidiaries of pharmaceutical company Mallinckrodt, have filed a patent infringement complaint against B Braun Medical.

More features

AbbVie blocks Humira antitrust suit
WATCH: Enabling success—mastering s112 in the new era of life sciences patents
AstraZeneca suffers defeat over $7bn diabetes patent
US firm Brownstein nabs five from Crowell ‘at pivotal moment’
American Regent secures rare PI win in Hatch-Waxman dispute
WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
J&J sues over schizophrenia drug generic following patent victory